Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization

OBJECTIVE: To assess whether progesterone (P4) or osteoblast P4 receptor-acting progestin (P) contributed to estrogen (E) therapy-related increased areal bone mineral density (BMD) in randomized controlled trials (RCT) with direct randomization to estrogen (ET) or estrogen-progestin (EPT) therapy. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Prior, J.C., Seifert-Klauss, V.R., Giustini, D., Adachi, J.D., Kalyan, S., Goshtasebi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601259/
https://www.ncbi.nlm.nih.gov/pubmed/28860416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601259/
https://www.ncbi.nlm.nih.gov/pubmed/28860416

Ejemplares similares